Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AffaMed Therapeutics Announces Approval for the Phase IIb Clinical Study of AM006 in China for the Treatment of Parkinson's Disease 2021-05-28 08:00
Viatris Signs Memorandum of Understanding with The Defeat NCD Partnership at the United Nations Institute for Training and Research (UNITAR) 2021-05-28 06:36
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis(IPF) shows promising result in early stage clinical test 2021-05-27 21:00
ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company 2021-05-27 17:00
Betagenon AB announces new CEO and new Chairman of the Board 2021-05-27 15:46
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization 2021-05-27 11:33
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China 2021-05-26 23:03
Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk Multiple Myeloma, Treatment Challenges and Dual-Targeting CAR-T with Overnight Manufacturing - a Novel Approach for Treatment of Multiple Myeloma 2021-05-26 21:00
TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China 2021-05-26 21:00
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand 2021-05-26 20:00
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19 2021-05-26 19:12
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP) 2021-05-26 05:00
I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets 2021-05-26 03:00
Nanoform and Celanese Explore Ways to Enhance Drug Delivery 2021-05-25 21:45
Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion 2021-05-25 15:33
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA 2021-05-25 08:30
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma 2021-05-25 08:00
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing 2021-05-24 20:00
Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States 2021-05-24 18:17
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™ 2021-05-24 17:00
1 242 243 244 245 246 413